Major owner of TREACE MEDICAL CONCEPTS, INC. just disposed of 165,000 shares

John T. Treace, a major owner of TREACE MEDICAL CONCEPTS, INC. and TREACE MEDICAL CONCEPTS, INC.'s Chief Executive Officer and a director of the company, recently disposed of 165,000 shares of the company. The disposals took place at prices ranging from $17.37 to $19.11 per share, on dates ranging from November 22 to November 24, 2021. Treace still owns 10,911,709 shares of the company. Treace operates out of Ponte Vedra, FL. Some additional info was provided as follows:


Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.01 to $19.00
inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon
request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.02 to $19.54 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon
request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.14 to $17.66 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon
request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.21 to $18.47 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon
request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.94 to $17.93 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon
request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.94 to $18.09 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon
request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever TREACE MEDICAL CONCEPTS, INC. makes a similar move, sign up!

Other recent filings from the company include the following:

SVP of TREACE MEDICAL CONCEPTS, INC. just cashed-in 47,700 options - Jan. 12, 2022
Treace Medical Concepts Provides 2021 Preliminary Sales Results - Jan. 12, 2022
CIBC Private Wealth Group, LLC just provided an update on share ownership of TREACE MEDICAL CONCEPTS, INC. - Jan. 7, 2022
SVP of TREACE MEDICAL CONCEPTS, INC. just cashed-in 2,300 options - Jan. 5, 2022
Major owner of TREACE MEDICAL CONCEPTS, INC. just disposed of 22,835 shares - Dec. 30, 2021

Auto Refresh

Feedback